Accelerated Technology Laboratories, Inc. (ATL), a leader in Laboratory Information Management Solutions (LIMS), is excited to announce a strategic partnership with Sequence Inc., a leading provider of quality and compliance solutions. Sequence, based in Morrisville, NC, is now an ATL Certified Delivery Partner and can provide ATL’s customers with a comprehensive spectrum of services including LIMS implementation, configuration and customization assistance and LIMS needs assessments. Sequence will also partner with ATL at industry conferences and seminars as both a speaker and exhibitor.
Sequence began in 2002 as a validation consulting firm in response to the need for top-level validation consultants, particularly in the Biopharma industry. Over the years, the company has grown from a small group of computer validation consultants to a comprehensive consulting firm providing computer, equipment, process, automation, utility, and lab instrument validation services. As a leader in the validation services industry, Sequence services also include project management services, software configuration and administration, internal/external quality auditing, development of new quality systems, remediation services, process optimization and more.
As a Certified Delivery Partner, Sequence will deliver technical services on behalf of ATL. This will allow ATL to provide quicker turnaround times on customizations, reports, parsers, remote training, onsite training, needs assessments, optimization assessments, and other professional services offered by ATL. In addition, Sequence will be ATL’s recommended partner if customers require LIMS and laboratory validation services.
“We are excited to announce this partnership with Sequence”, said Steve Chase, Chief Executive Officer at ATL. “They have an established reputation providing validation services as well as implementing LIMS and laboratory automation solutions. We have complete confidence in their capabilities and look forward to working together and delivering on our mutual commitment to complete customer satisfaction”.
“The combination of our validation services with ATL’s LIMS offerings presents our clients with a streamlined approach to quality”, said Daniel Santarsiero, Vice President of Business Development at Sequence. “It will reduce cost and expedite time to market for life-saving drugs benefiting our customers and patients alike. We are excited to join forces with ATL, a leader in Laboratory Information Management solutions.”
